http://investor.aradigm.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165Aradigm Corporation - All News Releasesen-usShareholder.com RSS Feedhttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=766164Tue, 21 May 2013 11:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=766164Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin™http://investor.aradigm.com/releasedetail.cfm?ReleaseID=764499Tue, 14 May 2013 11:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=764499Aradigm Announces First Quarter 2013 Financial Resultshttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=750984Tue, 26 Mar 2013 11:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=750984Aradigm Announces Fourth Quarter 2012 and Full Year Financial Resultshttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=738339Wed, 06 Feb 2013 12:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=738339Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2013 on February 12http://investor.aradigm.com/releasedetail.cfm?ReleaseID=731245Thu, 03 Jan 2013 12:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=731245Aradigm to Present at Biotech Showcase 2013 on January 9http://investor.aradigm.com/releasedetail.cfm?ReleaseID=726311Wed, 12 Dec 2012 12:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=726311Aradigm Announces Private Placement for $6 Millionhttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=722253Mon, 19 Nov 2012 12:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=722253UK Scientists Report on Efficacy of Aradigm's Lipoquin™ Against Pneumonic Plaguehttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=719644Thu, 08 Nov 2012 12:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=719644Aradigm Announces Third Quarter 2012 Financial Resultshttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=713676Tue, 16 Oct 2012 11:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=713676Virginia Commonwealth University Scientists Report Anti-Inflammatory Effect of Aradigm's Inhaled Liposomal Ciprofloxacinhttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=708247Thu, 20 Sep 2012 11:00:00 GMThttp://investor.aradigm.com/releasedetail.cfm?ReleaseID=708247UK Scientists Report Successful Testing of Aradigm's Inhaled Liposomal Ciprofloxacin in Q Fever